Evidence map›Paper›PMID 40406776›Full record

ArticleCureus2025

A Case of Fulminant Type 1 Diabetes With Residual Insulin Secretion.

Tomoko Kato, Norio Harada, Yuki Nishikawa, Kana Yamamoto, Takaaki Murakami, Yohei Ueda, Motozumi Okamoto, Daisuke Yabe

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomoko KatoDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.
Norio HaradaEndocrinology and Metabolism, University of Fukui School of Medical Sciences, Fukui, JPN.
Yuki NishikawaDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.
Kana YamamotoDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.
Takaaki MurakamiDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.
Yohei UedaDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.
Motozumi OkamotoInternal Medicine, Otsu-Shiga Red Cross Hospital, Otsu, JPN.
Daisuke YabeDiabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 67-year-old woman presented with fever and a cold a week later, with symptoms of hyperglycemia. After 10 days, her non-fasting blood glucose level was 586 mg/dL, and glycosylated hemoglobin (HbA1c) was 7.2%. She then developed diabetic ketosis and was treated with insulin. Her fasting C-peptide immunoreactivity (CPR) became 0.4 ng/mL. However, her insulin requirement was subsequently reduced. After two months, her CPR was 1.07 ng/mL at zero minutes and 2.04 ng/mL at six minutes in a glucagon stimulation test. Daily urinary CPR was 62 mg. Even though fulminant type 1 diabetes was indicated from the clinical course, insulin secretory ability improved.

Indexed as

fulminant type 1 diabetesinsulin secretory abilityketosisresidual insulin secretiontype 1 diabetes

Identifiers

PMID40406776
PMCPMC12095886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.